RESMED INC — Director's Dealing 2024

Oct 8, 2024

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

Form 144 Filer Information

Form 144

FORM 144

NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

144: Filer Information

144: Filer Information
Filer CIKFiler CCCIs this a LIVE or TEST Filing?
	0001485164
	XXXXXXXX
	LIVETEST

Submission Contact Information

Name Phone E-Mail Address

144: Issuer Information

144: Issuer Information
Name of IssuerSEC File NumberAddress of IssuerPhoneName of Person for Whose Account theSecurities are To Be Sold
	RESMED INC
	001-15317
	9001 SPECTRUM CENTER BLVD.SAN DIEGOCALIFORNIA92123
	8587462400
	Farrell Michael J.

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer Officer Relationship to Issuer Director

144: Securities Information

Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To BeSoldAggregate Market ValueNumber of Shares or Other UnitsOutstandingApproximate Date of SaleName the Securities Exchange	Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To BeSoldAggregate Market ValueNumber of Shares or Other UnitsOutstandingApproximate Date of SaleName the Securities Exchange	Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To BeSoldAggregate Market ValueNumber of Shares or Other UnitsOutstandingApproximate Date of SaleName the Securities Exchange
			Common
			Fidelity Brokerage Services LLC900 Salem StreetSmithfieldRI02917
			14683
			3405206.33
			146932119
Approximate	Date of Sale
			10/07/2024

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Amount of Securities AcquiredDate of PaymentNature of Payment
	Common
	10/07/2024
	Option Granted- 11/16/2017
	Issuer
	Date Donor Acquired
	14683
	10/07/2024
	Cash

If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
	Michael Farrell9001 Spectrum Center Blvd.San DiegoCA92123
	Common
	07/08/2024
	14683
	2833330.06

Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
	Michael Farrell9001 Spectrum Center Blvd.San DiegoCA92123
	Common
	08/07/2024
	14683
	3145904.70

144: Securities Sold During The Past 3 Months

Name and Address of Seller Michael Farrell 9001 Spectrum Center Blvd. San Diego CA 92123 Title of Securities Sold Common

Date of Sale 09/09/2024 Amount of Securities Sold 14683 Gross Proceeds 3646950.33

144: Remarks and Signature

Remarks
Date of Notice	10/07/2024
Date of Plan Adoption or Giving of	01/31/2024
Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature /s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Michael Farrell

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)